ERBB2 and breast cancer: Although these findings were colored by the molecular subtypes of breast cancer with TP53 most often being mutated in the HER2- and Basal-like subtypes26, notable differences in mutation frequencies were observed in their mutation profiles, suggesting differences in their cancer genome profiles comparing necrosis positive versus non-necrosis tumors.